Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Mar-22 7:34 PM View:  | Cytokinetics Inc. (CYTK) | 15-Mar-22 | Option Exercise | 60,817 | $10.67 | $648,636.00 | 90% 67.79K to 128.6K | |
| 15-Mar-22 7:34 PM View: | Cytokinetics Inc. (CYTK) | 15-Mar-22 | Option Sale | 25,196 | $33.96 | $855,724.00 | (20%) 128.6K to 103.41K | |
| 08-Mar-22 6:47 PM View: | Cytokinetics Inc. (CYTK) | 07-Mar-22 | Payment of Exercise | 4,631 | $36.83 | $170,560.00 | (6%) 72.42K to 67.79K | 3% |
| 03-Mar-22 4:41 PM View: | Cytokinetics Inc. (CYTK) | 02-Mar-22 | Grant | 20,000 | -- | -- | 36% 55.88K to 75.88K | |
| 03-Mar-22 4:41 PM View: | Cytokinetics Inc. (CYTK) | 02-Mar-22 | Payment of Exercise | 3,457 | $37.63 | $130,087.00 | (5%) 75.88K to 72.42K | |
| 17-Feb-22 7:48 PM View: | Cytokinetics Inc. (CYTK) | 16-Feb-22 | Grant | 5,025 | -- | -- | 10% 50.85K to 55.88K | |
| 20-Oct-21 6:57 PM View: | Cytokinetics Inc. (CYTK) | 19-Oct-21 | Option Exercise | 19,979 | $7.03 | $140,452.00 | 39% 50.85K to 70.83K | |
| 20-Oct-21 6:57 PM View: | Cytokinetics Inc. (CYTK) | 19-Oct-21 | Market Option Sale (Planned) | 19,979 | $35.74 | $713,970.00 | (28%) 70.83K to 50.85K | |
| 09-Mar-21 6:56 PM View: | Cytokinetics Inc. (CYTK) | 08-Mar-21 | Payment of Exercise | 4,150 | $19.19 | $79,638.50 | (8%) 55.0K to 50.85K | 0% |
| 04-Mar-21 4:57 PM View: | Cytokinetics Inc. (CYTK) | 02-Mar-21 | Grant | 25,000 | -- | -- | 83% 30.0K to 55.0K | |
| 21-Aug-20 5:34 PM View: | Cytokinetics Inc. (CYTK) | 21-Aug-20 | Option Exercise | 10,000 | $7.03 | $70,300.00 | 33% 30.0K to 40.0K | |
| 21-Aug-20 5:34 PM View: | Cytokinetics Inc. (CYTK) | 21-Aug-20 | Market Option Sale (Planned) | 10,000 | $25.00 | $250,000.00 | (25%) 40.0K to 30.0K | 16% |
| 30-Jul-20 7:57 PM View: | Cytokinetics Inc. (CYTK) | 29-Jul-20 | Option Exercise | 10,000 | $7.03 | $70,300.00 | 33% 30.0K to 40.0K | |
| 30-Jul-20 7:57 PM View: | Cytokinetics Inc. (CYTK) | 29-Jul-20 | Market Option Sale (Planned) | 10,000 | $23.07 | $230,728.00 | (25%) 40.0K to 30.0K | 9% |
| 09-Mar-20 4:33 PM View: | Cytokinetics Inc. (CYTK) | 06-Mar-20 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 08-May-18 4:16 PM View: | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 68,251 | -- | -- | (100%) 68.25K to 0 | |
| 05-Mar-18 12:47 PM View: | Impax Laboratories, LLC (IPXL) | 02-Mar-18 | Payment of Exercise | 3,273 | $19.50 | $63,823.50 | (4%) 92.52K to 89.25K | 6% |
| 27-Feb-18 12:18 PM View: | Impax Laboratories, LLC (IPXL) | 26-Feb-18 | Payment of Exercise | 5,937 | $20.95 | $124,380.00 | (6%) 98.46K to 92.52K | 13% |
| 16-May-17 2:56 PM View: | Impax Laboratories, LLC (IPXL) | 15-May-17 | Payment of Exercise | 3,488 | $16.80 | $58,598.40 | (3%) 101.94K to 98.46K | (9%) |
| 16-May-17 2:56 PM View: | Impax Laboratories, LLC (IPXL) | 14-May-17 | Payment of Exercise | 3,235 | $17.65 | $57,097.80 | (3%) 105.18K to 101.94K | (4%) |
| 06-Mar-17 3:08 PM View: | Impax Laboratories, LLC (IPXL) | 02-Mar-17 | Grant | 23,272 | -- | -- | 28% 81.91K to 105.18K | |
| 27-Feb-17 8:22 PM View: | Impax Laboratories, LLC (IPXL) | 26-Feb-17 | Payment of Exercise | 6,014 | $14.05 | $84,496.70 | (7%) 87.92K to 81.91K | (30%) |
| 24-May-16 1:19 PM View: | Impax Laboratories, LLC (IPXL) | 23-May-16 | Payment of Exercise | 1,095 | $32.12 | $35,171.40 | (1%) 89.02K to 87.92K | 43% |
| 16-May-16 3:42 PM View: | Impax Laboratories, LLC (IPXL) | 15-May-16 | Payment of Exercise | 2,330 | $29.18 | $67,989.40 | (3%) 91.35K to 89.02K | 37% |
| 16-May-16 3:42 PM View: | Impax Laboratories, LLC (IPXL) | 14-May-16 | Payment of Exercise | 2,163 | $29.18 | $63,116.30 | (2%) 93.51K to 91.35K | 37% |
| 01-Mar-16 4:14 PM View: | Impax Laboratories, LLC (IPXL) | 26-Feb-16 | Grant | 21,852 | -- | -- | 30% 73.59K to 95.44K | |
| 01-Mar-16 4:14 PM View: | Impax Laboratories, LLC (IPXL) | 26-Feb-16 | Payment of Exercise | 1,931 | $33.27 | $64,244.40 | (2%) 95.44K to 93.51K | 45% |
| 14-Sep-15 7:13 PM View: | Impax Laboratories, LLC (IPXL) | 11-Sep-15 | Market Sale | 7,457 | $43.30 | $322,888.00 | (9%) 81.05K to 73.59K | 58% |
| 27-Aug-15 8:08 PM View: | Impax Laboratories, LLC (IPXL) | 27-Aug-15 | Market Sale | 4,649 | $43.41 | $201,813.00 | (5%) 85.69K to 81.05K | 58% |
| 09-Jul-15 12:44 PM View: | Impax Laboratories, LLC (IPXL) | 08-Jul-15 | Payment of Exercise | 3,916 | $45.99 | $180,097.00 | (4%) 89.61K to 85.69K | 60% |
| 26-May-15 12:26 PM View: | Impax Laboratories, LLC (IPXL) | 23-May-15 | Payment of Exercise | 1,102 | $46.21 | $50,923.40 | (1%) 90.71K to 89.61K | 60% |
| 19-May-15 12:15 PM View: | Impax Laboratories, LLC (IPXL) | 15-May-15 | Payment of Exercise | 2,330 | $44.44 | $103,545.00 | (3%) 93.04K to 90.71K | 59% |
| 19-May-15 12:12 PM View: | Impax Laboratories, LLC (IPXL) | 14-May-15 | Payment of Exercise | 2,163 | $44.82 | $96,945.70 | (2%) 95.2K to 93.04K | 59% |
| 12-Mar-15 2:23 PM View: | Impax Laboratories, LLC (IPXL) | 26-Feb-15 | Grant | 20,000 | -- | -- | 27% 75.2K to 95.2K | |
| 16-Jul-14 8:26 PM View: | Impax Laboratories, LLC (IPXL) | 08-Jul-14 | Payment of Exercise | 2,819 | $28.80 | $81,187.20 | (4%) 78.02K to 75.2K | 36% |
| 28-May-14 2:44 PM View: | Impax Laboratories, LLC (IPXL) | 23-May-14 | Payment of Exercise | 815 | $27.89 | $22,730.30 | (1%) 78.84K to 78.02K | 34% |
| 16-May-14 2:56 PM View: | Impax Laboratories, LLC (IPXL) | 15-May-14 | Payment of Exercise | 2,330 | $25.56 | $59,554.80 | (3%) 81.17K to 78.84K | 28% |
| 16-May-14 2:56 PM View: | Impax Laboratories, LLC (IPXL) | 14-May-14 | Grant | 23,000 | -- | -- | 40% 58.17K to 81.17K | |
| 09-Jul-13 4:33 PM View: | Impax Laboratories, LLC (IPXL) | 08-Jul-13 | Payment of Exercise | 2,752 | $20.33 | $55,950.90 | (5%) 60.92K to 58.17K | 10% |
| 28-May-13 8:15 PM View: | Impax Laboratories, LLC (IPXL) | 23-May-13 | Payment of Exercise | 795 | $18.60 | $14,787.00 | (1%) 61.72K to 60.92K | 2% |
| 16-May-13 5:29 PM View: | Impax Laboratories, LLC (IPXL) | 15-May-13 | Grant | 24,800 | -- | -- | 67% 36.92K to 61.72K | |
| 14-Mar-13 7:05 PM View: | Impax Laboratories, LLC (IPXL) | 12-Mar-13 | Market Purchase | 1,000 | $16.73 | $16,728.00 | 3% 35.92K to 36.92K | 9% |
| 09-Jul-12 3:06 PM View: | Impax Laboratories, LLC (IPXL) | 08-Jul-12 | Payment of Exercise | 2,751 | $20.25 | $55,707.80 | (7%) 38.67K to 35.92K | 10% |
| 25-May-12 1:53 PM View: | Impax Laboratories, LLC (IPXL) | 23-May-12 | Grant | 8,667 | -- | -- | 29% 30.0K to 38.67K | |
| 11-Jul-11 6:10 PM View: | Impax Laboratories, LLC (IPXL) | 08-Jul-11 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K |